Adherence to the Sociedad Espanola de Oncologia Medica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study
Por:
Henao F, Manzano A, Lopez R, Gobartt A, de las Penas R
Ahead of Print:
1 oct 2020
Resumen:
Plain Language Summary Low levels of sodium in the blood occur in almost half of patients with cancer who are hospitalized. In some patients, this may be fatal. A care pathway was developed by the Sociedad Espanola de Oncologia Medica in 2014 to support doctors in providing the best care for these patients. Clinical records for 70 patients with cancer at four Spanish hospitals were reviewed to determine whether treatment was given according to the care pathway. Less than one-third of patients were found to have been treated according to the pathway. Patients receiving chemotherapy were more likely to have been treated according to the pathway; however, doctors believed that more patients were treated in line with the pathway. In general, health outcomes were similar for those patients treated according to and not treated according to the pathway. The difference between doctors' belief that the pathway was followed when it might not have been needs to be examined further, say the authors. They suggest several reasons for the difference. The doctor providing feedback on whether the patient was treated according to the pathway may not have been the only doctor involved in a patient's care and may not have been aware of all the treatment choices made. Lack of clarity within the pathway may have led doctors to believe that it was being followed more often than it was. Importantly, a doctor's judgment may need to override pre-defined pathways in some situations to achieve the best outcome for the patient.
Introduction The ALGA study explored adherence of Spanish treatment centers to the Sociedad Espanola de Oncologia Medica (SEOM) treatment algorithm for oncology patients with hyponatremia that requires treatment as the main cause of hospitalization, and evaluated the impact of adherence to this algorithm on patient outcomes. Methods This retrospective study recruited patients aged at least 18 years with cancer, treated for at least one episode of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The primary outcome was the proportion of patients whose treatment adhered to the SEOM algorithm, evaluated using a pre-defined decision tree. Secondary outcomes included length of hospitalization, and time to serum sodium level improvement. Perceived center adherence to the SEOM algorithm was also assessed. Results Seventy patients from four treatment centers were included. Twenty (28.6%; 95% confidence interval [CI] 18.0, 39.2) patients on hyponatremia treatment adhered to the SEOM algorithm, with a perceived adherence of 51.0-75.0%. Algorithm adherence in candidates for chemotherapy was 36.4% (n = 8) versus 25.0% (n = 12) for non-candidates for chemotherapy. Median time to serum sodium level improvement in patients managed adherently was 80.5 h (95% CI 38.3, 331.4) versus 134.6 h (33.2, 444.9) in patients managed non-adherently. Median time to hospital discharge was 16.5 days (95% CI 8.0, 27.0) in patients managed adherently versus 9.5 days (7.0, 22.0) in patients managed non-adherently. Conclusion In Spanish centers, the SEOM algorithm was adhered to in less than one-third of patients, in contrast to higher levels of perceived adherence. This requires further investigation; however, algorithm use could require further clarification, especially in non-candidates for chemotherapy.
Filiaciones:
Henao F:
Hosp Univ Virgen Macarena, Med Oncol Dept, Calle Dr Fedriani 3, Seville 41009, Spain
Manzano A:
Hosp Clin San Carlos, Serv Med Oncol, Calle Prof Martin Lagos S-N, Madrid 28040, Spain
Lopez R:
Complejo Hosp Univ Santiago, Dept Oncol, CIBERONC, Rua Choupana S-N, Santiago De Compostela 15706, Spain
Gobartt A:
Otsuka Pharmaceut SA, Med Manager Hosp Unit, Ave Diagonal 615, Barcelona 08025, Spain
de las Penas R:
Consorcio Hosp Prov Castellon, Dept Oncol, Ave Doctor Clara 19, Castellon de La Plana 12002, Spain
|